Disclosures for "Rising Mortality Related to Early-Onset Alzheimer’s Disease in the United States: Trends and Disparities 2003-2023"
-
Miss Kennedy has nothing to disclose.
-
Mr. Song has nothing to disclose.
-
Ms. Hackett has nothing to disclose.
-
Dr. Al-Salahat has nothing to disclose.
-
Dr. Verma has nothing to disclose.
-
Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.